Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Cipla
Teva
Mallinckrodt
Julphar
UBS
Citi
Dow
Fish and Richardson
Chinese Patent Office

Generated: December 10, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020885

« Back to Dashboard

NDA 020885 describes PAXIL, which is a drug marketed by Apotex Technologies and is included in four NDAs. It is available from two suppliers. There are five patents protecting this drug and three Paragraph IV challenges. Additional details are available on the PAXIL profile page.

The generic ingredient in PAXIL is paroxetine hydrochloride. There are thirty drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the paroxetine hydrochloride profile page.

Summary for 020885

Tradename:1
Applicant:1
Ingredient:1
Patents:3
Therapeutic Class:Antidepressants
Anxiolytics
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrengthEQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Oct 9, 1998TE:RLD:Yes
Patent:► SubscribePatent Expiration:Oct 23, 2019Product Flag?Substance Flag?Delist Request?Y
Patent:► SubscribePatent Expiration:Sep 17, 2017Product Flag?Substance Flag?Delist Request?Y
Patent:► SubscribePatent Expiration:Jul 15, 2018Product Flag?Substance Flag?Delist Request?Y

Expired Orange Book Patents for NDA: 020885

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apotex TechnologiesPAXILparoxetine hydrochlorideCAPSULE;ORAL020885-002Oct 9, 1998► Subscribe► Subscribe
Apotex TechnologiesPAXILparoxetine hydrochlorideCAPSULE;ORAL020885-004Oct 9, 1998► Subscribe► Subscribe
Apotex TechnologiesPAXILparoxetine hydrochlorideCAPSULE;ORAL020885-002Oct 9, 1998► Subscribe► Subscribe
Apotex TechnologiesPAXILparoxetine hydrochlorideCAPSULE;ORAL020885-002Oct 9, 1998► Subscribe► Subscribe
Apotex TechnologiesPAXILparoxetine hydrochlorideCAPSULE;ORAL020885-002Oct 9, 1998► Subscribe► Subscribe
Apotex TechnologiesPAXILparoxetine hydrochlorideCAPSULE;ORAL020885-004Oct 9, 1998► Subscribe► Subscribe
Apotex TechnologiesPAXILparoxetine hydrochlorideCAPSULE;ORAL020885-001Oct 9, 1998► Subscribe► Subscribe
Apotex TechnologiesPAXILparoxetine hydrochlorideCAPSULE;ORAL020885-002Oct 9, 1998► Subscribe► Subscribe
Apotex TechnologiesPAXILparoxetine hydrochlorideCAPSULE;ORAL020885-001Oct 9, 1998► Subscribe► Subscribe
Apotex TechnologiesPAXILparoxetine hydrochlorideCAPSULE;ORAL020885-004Oct 9, 1998► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
US Army
Fuji
Chinese Patent Office
Federal Trade Commission
McKinsey
Merck
Covington
UBS
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot